PRE Prenetics Global Limited: Net earnings per share for the last four quarters

Public company logo of Prenetics Global Ltd (PRE)

Prenetics Global dominates the personalized medicine segment by making genetic testing accessible to the general population. High barriers to entry are created by rapid diagnostic patents and an extensive Asian laboratory network. Reagent supply is secured through long-term deals and digital logistics. The current figure stands at -5.40, which the EPS (TTM) price visualization below confirms.

PRE - Prenetics Earnings per share for the last twelve months over the range 02/11/2024 - 11/15/2026

PRE (Prenetics Global Limited): analytical breakdowns and indicator data

- market price and analyst price targets:
Market Chart Prenetics|PRE - Price Target Chart
- company stock capitalization data:
Market Capitalization Prenetics Global|PRE - Total Company Value
- book value of equity indicators:
Share Book Value Prenetics|PRE - Company Book Value|Market Value to Book Value prenetics.com|PRE - Company Total Assets
- debt and liquidity data:
Debt to Capital Prenetics Global|PRE - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio prenetics.com|PRE - Company Aggregate Debts|Debts to Book Value Prenetics|PRE - Company Long-Term Liabilities|Amount of Current Liabilities Prenetics|Interim Coverage Ratio prenetics.com
- earnings and market ratios statistics:
PRE - Net Profit|Future Profit Prenetics Global|PRE - Price to Earnings Ratio|Market Cap to Projected Earnings Prenetics Global Limited|PRE - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Prenetics Global Ltd|PRE - Operating profit EBITDA|Net earnings per share for the trailing year Prenetics|PRE - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months prenetics.com|PRE - Earnings per share growth in current year|Expected net earnings per share growth next year Prenetics Global
- revenue and sales details:
PRE - Revenue and Sales Volume|Company Projected Revenue prenetics.com|PRE - P/S Multiple|Forward P/S Multiple Prenetics Global|PRE - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:PRE, Prenetics Global
Core merchandise of Prenetics

The annual growth rate of net income per share determines the actual speed of fundamental business development over twelve months. This metric compares current aggregate income with the same period last year, filtering out short-term market noise. Analyzing the EPS YoY TTM growth value helps determine trend sustainability and prevents overpaying for an asset. The patent protection of molecular diagnostics at Prenetics Global (PRE) creates barriers for competitors, ensuring the stability of this financial momentum.

Direct competitors

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Earnings per share for the last twelve months MDxHealth MDXH|LUCD: Earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)